Key insight: A large study will test whether matching patients’ genetic variants to known drug responses before they need treatment will improve health and economic outcomes.
Dr. Richard Weinshilboum is asking a big question: What if your doctor knew which drugs to treat you with before you got sick?
Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!
GET STARTEDWhat is it?
STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.
What's included?
- Daily reporting and analysis
- The most comprehensive industry coverage from a powerhouse team of reporters
- Subscriber-only newsletters
- Daily newsletters to brief you on the most important industry news of the day
- Online intelligence briefings
- Frequent opportunities to engage with veteran beat reporters and industry experts
- Exclusive industry events
- Premium access to subscriber-only networking events around the country
- The best reporters in the industry
- The most trusted and well-connected newsroom in the health care industry
- And much more
- Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
About the Author Reprints
The problem with pharmacogenomics is that that it is not a perfect predictor. Every patient represents a therapeutic trial with n=1. The best doctors know how to mix and match drugs. If you extend the case for predictive genomics then every doctor would rely on a Watson super computer for the correct drug and dosage. Even if Watson were affordable I know a few doctors that would trust one like Dave trusted HAL in “2001”.